Here at Aurora, we are pleased to release the first Access All Areas paper, ‘Creating opportunities for improving patients’ access to medicines.’ Access All Areas is a self-funded campaign which aims to both uncover and make a contribution to improving the variables affecting timely access to medicines in the UK. From this research, we have begun to facilitate constructive dialogue amongst the pharmaceutical industry, patient groups and the NHS.
The paper is based on bespoke research as well as stakeholder engagement and commentary from the Access All Areas inaugural meeting held at the Royal College of General Practitioners on 12 May 2015. The qualitative research was gained from focus groups and in-depth interviews with representatives from the pharmaceutical industry and patient organisations.
The paper is structured around seven key dependencies which have the ability to affect positive change in medicines access – these are analysed through a systems-thinking lens. Each dependency offers practical guidance and recommendations around improving patients’ access to medicines. The paper can be downloaded here. We have also created a LinkedIn group where the topic of patient access to innovative medicines can be discussed and the latest updates of the campaign will be shared – it can be accessed here.
Aurora’s work on Access All Areas continues – we are currently participating in the Office for Life Sciences Accelerated Access Review consultation process both directly and supporting and collaborating with a range of stakeholders.
We are also starting a programme of work on the best practice sharing dependency through a series of meetings with Royal Colleges, Academic Health Science Networks and other bodies involved in sharing best practice. Within the healthcare system, there are examples of successful timely uptake of medicines, however this best practice can become trapped within organisations – the best practice sharing dependency is about sharing both the protocols and principles of best practice to allow others to repeat these measures more quickly.
We welcome future collaborations with stakeholders, across the healthcare spectrum, to affect change and enhance patients’ access to innovative medicines and technologies. If you would like to get involved in future activities please email firstname.lastname@example.org or give Neil a call on +44 (0)20 7148 4170.